A detailed history of Lansforsakringar Fondforvaltning Ab (Publ) transactions in Boston Scientific Corp stock. As of the latest transaction made, Lansforsakringar Fondforvaltning Ab (Publ) holds 859,556 shares of BSX stock, worth $89.8 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
859,556
Previous 867,083 0.87%
Holding current value
$89.8 Million
Previous $77.4 Million 11.96%
% of portfolio
0.55%
Previous 0.45%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

SELL
$89.38 - $106.18 $672,763 - $799,216
-7,527 Reduced 0.87%
859,556 $86.7 Million
Q4 2024

Apr 14, 2025

BUY
$83.62 - $91.5 $72.5 Million - $79.3 Million
867,083 New
867,083 $77.4 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $150B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Lansforsakringar Fondforvaltning Ab (Publ) Portfolio

Follow Lansforsakringar Fondforvaltning Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lansforsakringar Fondforvaltning Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Lansforsakringar Fondforvaltning Ab (Publ) with notifications on news.